Table 2.
Diagnostic role of NLR by ROC curve analysis.
| Model | Cut-Off | Sensibility | Specificity | AUC | p | PPV | NPV |
|---|---|---|---|---|---|---|---|
| NLR | 7.97 | 64.26 | 80.16 | 0.74 | <0.001 | 86.49 | 53.18 |
| PLR | 370.59 | 29.3 | 92.1 | 0.56 | 0.037 | 87.99 | 39.72 |
| PCR | 37.88 | 78.75 | 93.51 | 0.92 | <0.0001 | 95.93 | 60.46 |
| PCT | 0.41 | 79.6 | 81.00 | 0.88 | <0.001 | 89.26 | 60.67 |
| MR-proADM | 1.83 | 80.1 | 74.6 | 0.86 | <0.0001 | 85.51 | 66.68 |
| SIRS | ≥2 | 67.3 | 89.7 | 0.57 | <0.001 | 96.77 | 43.30 |
| q-SOFA | ≥2 | 51.4 | 99.2 | 0.87 | <0.001 | 99.23 | 50.21 |
| SOFA | ≥2 | 69.7 | 71.4 | 0.77 | <0.001 | 82.94 | 54.21 |
Area under the curve (AUC); positive predictive value (PPV); negative predictive value (NPV). NLR, neutrophil-to-lymphocyte; PLR, platelet-to-lymphocyte; PCR, C-reactive protein; PCT, procalcitonin; MR-proADM, mid-regional pro-adrenomedullin; SIRS, systemic inflammatory response syndrome; SOFA, sequential organ failure assessment.